DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group
In Brief: Koprowski, Niederhuber, Engstrom Chair DCE, DCT, DCPC BSCs; Roentgen Ray Officers Named
NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor
NCI Searching for Scientists With “Fire in Belly” As Associate Director for Biological Carcinogenesis
Concepts Approved For Developmental Therapeutics Program
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore









